People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RADIENT PHARMACEUTICALS Corp | — | Pharmaceuticals | Series B | $42.5M | $612.1M | 2009 |
Edward R Arquilla at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Edward R Arquilla on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Akio Ariura | 1 | 2 |
| Douglas MacLellan | 1 | 2 |
| Michael Boswell | 1 | 2 |
| Michael R Boswell | 1 | 1 |
| Akio C Ariura | 1 | 1 |
| Minghui Jia | 1 | 1 |
| Robert Beart | 1 | 1 |
| Robert Rooks | 1 | 1 |
| Leonard Reyno | 1 | 1 |
| Douglas C MacLellan | 1 | 1 |
| Minghui (Henry) R Jia | 1 | 1 |
| Minghui R Jia | 1 | 1 |
| William M Thompson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.